Artelo Biosciences, Inc. (ARTL) vs Propanc Biopharma, Inc. (PPCB)

A side-by-side comparison of Artelo Biosciences, Inc. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Artelo Biosciences, Inc. logo
ARTL
Artelo Biosciences, Inc.
$1M
$3.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Propanc Biopharma, Inc. logo
PPCB
Propanc Biopharma, Inc.
$1M
$0.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ARTL vs PPCB

growth of $100 · dividends reinvested · last 6y
ARTL -99.6% (-59.5%/yr)PPCB -100.0% (-92.0%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $100202020212022202320242025$0$0
ARTL PPCB

ARTL vs PPCB: by the numbers

  • •ARTL is the larger company ($1M vs $1M market cap).

Metrics side by side

Valuation

MetricARTLPPCB
P/B ratio0.270.12

Profitability

MetricARTLPPCB
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-253.57%-200.63%
ROIC-219.36%-183.49%

Growth (annualized)

MetricARTLPPCB
Total return CAGR (5Y)-64.27%N/A

Go deeper

Full ARTL analysisFull PPCB analysisInteractive comparison tool

Dig into the metrics

Artelo Biosciences ROEPropanc Biopharma ROEArtelo Biosciences operating marginPropanc Biopharma operating marginArtelo Biosciences revenue growthPropanc Biopharma revenue growthArtelo Biosciences free cash flowPropanc Biopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.